Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma
City of Hope Medical Center
City of Hope Medical Center
Fred Hutchinson Cancer Center
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Mayo Clinic
Massachusetts General Hospital
Barbara Ann Karmanos Cancer Institute
Northwestern University
National Institutes of Health Clinical Center (CC)